Royalty Pharma plc Minority Interest

Royalty Pharma plc (RPRX) currently reports a minority interest of $91M as of June 2026. That compares with $3.2B in the prior-year period — down 97.1% year over year. Use the charts on this page to explore Royalty Pharma plc's minority interest history and peer comparisons.

Royalty Pharma plc's minority interest decreased from $3.2B to $91M — a 97.1% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Royalty Pharma plc reported $91M in minority interest as of June 2026. That compares with $3.2B in the prior-year period — down 97.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current minority interest of $91M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Royalty Pharma plc, and consider following RPRX for alerts when major investors trade the stock.

Royalty Pharma plc is classified in the Healthcare sector. On minority interest, it currently shows $91M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RPRX with unrelated industries.